cefmetazole has been researched along with cefamandole in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandsch, M; Luckner, P | 1 |
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
| de Waart, DR; Duijst, S; Kunne, C; Oude Elferink, RP; Paulusma, CC; van de Wetering, K | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Barba, D; Esposito, S; Galante, D | 1 |
| Brogard, JM; Comte, F | 1 |
| Fujimura, H; Nozaki, M; Okada, K; Tsurumi, K; Yanagihara, M | 1 |
| Ejiri, S; Fujita, Y; Haginaka, T; Hasegawa, M; Hirano, S; Ikeda, A; Iwasa, Y; Kameda, K; Kanda, S; Kato, M; Kawaguchi, S; Kitagawa, K; Kobayashi, T; Kojima, A; Kuroda, K; Mikawa, I; Miyagi, T; Miyazaki, K; Motoi, I; Nakajima, S; Nakamura, T; Nakashima, T; Nango, C; Ohkawa, M; Ohtaki, M; Okasho, A; Okumura, R; Sakai, A; Shimada, K; Shoda, R; Tajika, E; Takemae, K; Tanaka, T; Taya, T; Tokunaga, S; Tsukahara, K; Ueno, K; Watanabe, K | 1 |
| Ichishima, Y; Itoh, C; Kikuiri, T; Murakami, T; Nitta, Y; Ogi, M; Oshima, S; Tango, M; Ujiie, A; Yajima, O | 1 |
| Matsuo, K; Uete, T | 2 |
1 review(s) available for cefmetazole and cefamandole
| Article | Year |
|---|---|
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
2 trial(s) available for cefmetazole and cefamandole
| Article | Year |
|---|---|
[A double blind clinical trial of cefamandole and cefmetazole in complicated urinary tract infections].
Topics: Adolescent; Adult; Aged; Bacteria; Cefamandole; Cefmetazole; Cephalosporins; Cephamycins; Clinical Trials as Topic; Double-Blind Method; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 1983 |
[Double-blind comparative clinical evaluation of cefamandole and cefmetazole in the treatment of respiratory tract infections].
Topics: Adolescent; Adult; Aged; Cefamandole; Cefmetazole; Cephamycins; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Respiratory Tract Infections | 1983 |
11 other study(ies) available for cefmetazole and cefamandole
| Article | Year |
|---|---|
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |
Oral availability of cefadroxil depends on ABCC3 and ABCC4.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Biological Transport; Cefadroxil; Cell Membrane; Enterocytes; Estradiol; Intestinal Absorption; Intestinal Mucosa; Jejunum; Mice; Mice, Knockout; Multidrug Resistance-Associated Proteins | 2012 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
Topics: Bacteria; Cefamandole; Cefmetazole; Cefotaxime; Cefoxitin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephamycins; Citrobacter; Enterobacter; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Proteus; Pseudomonas; Staphylococcus; Streptococcus | 1986 |
[Cephem antibiotics and alcohol metabolism: (1) Disulfiram-like reaction resulting from intravenous administration of cephem antibiotics].
Topics: Acetaldehyde; Administration, Oral; Animals; Cefamandole; Cefazolin; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Cephamycins; Disulfiram; Drug Interactions; Ethanol; Injections, Intravenous; Male; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1982 |
Synergistic enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. I. Effect of NaCl.
Topics: Cefamandole; Cefazolin; Cefmetazole; Cefoperazone; Cefotiam; Drug Combinations; Drug Synergism; Methicillin; Methicillin Resistance; Sodium Chloride; Staphylococcus aureus | 1995 |
Synergistic enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. II. Effect of inoculum size.
Topics: Bacteriological Techniques; Cefamandole; Cefmetazole; Cefoperazone; Cefotiam; Drug Combinations; Drug Synergism; Methicillin; Methicillin Resistance; Staphylococcus aureus | 1995 |